Physician profile
Stephen Slocum
NPI 1669418109
$1,152.81
in general payments reported to CMS, 2019-2025
22 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.76 · 2020: $91.36 · 2021: $161 · 2022: $169 · 2023: $290 · 2024: $161 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $170.10 | 2019-2025 | Clareon, Argos, Eysuvis |
| Abbvie INC. | $154.82 | 2022-2024 | Lumigan, Alphagan P |
| Allergan, INC. | $96.73 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $89.40 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $84.73 | 2023-2024 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $65.51 | 2019-2020 | |
| Thea Pharma INC. | $64.06 | 2023-2025 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $59.50 | 2019-2023 | Acuvue |
| Harrow Eye, LLC | $40.99 | 2024 | Vevye |
| Menicon America INC | $39.13 | 2021 | |
| Bausch & Lomb Americas INC. | $37.04 | 2023-2025 | Xiidra, Miebo |
| Biotissue Holdings INC. | $32.68 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $32.02 | 2025 | Xdemvy |
| Glaukos Corporation | $27.48 | 2024 | Ce-Marked Kxla System |
| Astellas Pharma US INC | $26.48 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis, INC | $24.85 | 2021 | |
| Coopervision INC. | $22.09 | 2022 | |
| Amgen INC. | $20.06 | 2025 | Tepezza |
| Horizon Therapeutics Plc | $18.05 | 2020 | |
| Eyevance Pharmaceuticals LLC | $17.60 | 2022 | |
| Aerie Pharmaceuticals, INC. | $16.74 | 2020 | |
| Shire North American Group INC | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Slocum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.